Platform
Features
NATA - Nucleic Acid Therapy Accelerator
Contact
No bio yet
Shalini Andersson
Chief Scientist Of New Therapeutic Modalities And Head Of Oligonucleotide Discovery, Astrazeneca (sweden)
Sign up to view 0 direct reports
Get started
4 members
7 members
Ad
PCM Trials
Toyota Research Institute
Garvan Institute of Medical Research
Fortune Business Insights
The Aurum Institute